AAVantgarde announced completion of recruitment in its STELLA natural history study.
AAVantgarde is a biotechnology company focused on gene therapies for inherited retinal diseases, developing large gene delivery platforms for therapeutic programs
AAVantgarde is a biotechnology company focused on gene therapies for inherited retinal diseases, developing large gene delivery platforms for therapeutic programs.